PharmacyCodes



Novobiocina [Inn-Spanish] en es it fr

Novobiocina [Inn-Spanish] Brand names, Novobiocina [Inn-Spanish] Analogs

Novobiocina [Inn-Spanish] Brand Names Mixture

  • Albacillin Suspension (Novobiocin (Novobiocin Sodium) + Penicillin G Procaine)
  • Delta-Albaplex Tablets (Novobiocin (Novobiocin Sodium) + Prednisolone + Tetracycline Hydrochloride)
  • Novodry Plus Suspension (Novobiocin (Novobiocin Sodium) + Penicillin G Procaine)
  • Special Formula 17900-Forte Suspension (Dihydrostreptomycin (Dihydrostreptomycin Sulfate) + Hydrocortisone Acetate + Hydrocortisone Sodium Succinate + Novobiocin (Novobiocin Sodium) + Penicillin G Procaine + Polymyxin B Sulfate)

Novobiocina [Inn-Spanish] Chemical_Formula

C31H36N2O11

Novobiocina [Inn-Spanish] RX_link

No information avaliable

Novobiocina [Inn-Spanish] fda sheet

Novobiocina [Inn-Spanish] msds (material safety sheet)

Novobiocina_[Inn-Spanish] MSDS

Novobiocina [Inn-Spanish] Synthesis Reference

No information avaliable

Novobiocina [Inn-Spanish] Molecular Weight

612.624 g/mol

Novobiocina [Inn-Spanish] Melting Point

No information avaliable

Novobiocina [Inn-Spanish] H2O Solubility

Insoluble

Novobiocina [Inn-Spanish] State

Solid

Novobiocina [Inn-Spanish] LogP

2.737

Novobiocina [Inn-Spanish] Dosage Forms

Drug premix; Suspension

Novobiocina [Inn-Spanish] Indication

For the treatment of infections due to staphylococci and other susceptible organisms

Novobiocina [Inn-Spanish] Pharmacology

Novobiocin is an aminoglycoside antibiotic. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit, causing misreading of t-RNA, leaving the bacterium unable to synthesize proteins vital to its growth. Aminoglycosides are useful primarily in infections involving aerobic, Gram-negative bacteria, such as Pseudomonas, Acinetobacter, and Enterobacter. In addition, some mycobacteria, including the bacteria that cause tuberculosis, are susceptible to aminoglycosides. Infections caused by Gram-positive bacteria can also be treated with aminoglycosides, but other types of antibiotics are more potent and less damaging to the host. In the past the aminoglycosides have been used in conjunction with penicillin-related antibiotics in streptococcal infections for their synergistic effects, particularly in endocarditis. Aminoglycosides are mostly ineffective against anaerobic bacteria, fungi and viruses.

Novobiocina [Inn-Spanish] Absorption

No information avaliable

Novobiocina [Inn-Spanish] side effects and Toxicity

No information avaliable

Novobiocina [Inn-Spanish] Patient Information

No information avaliable

Novobiocina [Inn-Spanish] Organisms Affected

Enteric bacteria and other eubacteria